A federal court decision that struck down expanded use of copay accumulator programs should prompt health insurers and pharmacy benefit managers to closely review their policies and practices, Mintz attorneys say.
Drugmakers’ victory in HIV and Hepatitis Policy Institute v. HHS will change how insurers and pharmacy benefit managers interact with patient copay assistance programs, as well as affect the many companies that contract with insurers to provide health coverage for their employees.
Comments